Geschreven door Margot van Dijk
Gepubliceerd op 14 februari 2022
In Nederland krijgt 0,1 tot 2,0% van de zwangeren in de tweede helft van de zwangerschap te maken met hevige jeuk in combinatie met een hoge waarde van galzure zouten in het bloed. Oftewel; zwangerschapscholestase. Meestal wordt de baring eerder ingeleid vanwege de mogelijke complicaties die kunnen optreden bij zwangerschapscholestase. Het beleid kan verschillen: niet alle ziekenhuizen houden dezelfde afkapwaarden van galzure zouten in het bloed aan. Wat is zwangerschapscholestase nu precies? Wat zijn de mogelijke complicaties en wat is de kans dat deze optreden? Heeft eerder inleiden zin? Deze en andere vragen worden beantwoord in dit artikel.
Inhoud volledige artikel:
- Wat is zwangerschapscholestase?
- Welke factoren beïnvloeden het ontstaan van cholestase in de zwangerschap?
- Wie heeft er een verhoogde kans op het ontstaan van zwangerschapscholestase?
- Wat is het risico van zwangerschapscholestase voor de baby?
- Wat is het risico van zwangerschapscholestase voor de zwangere?
- Wat is het huidige beleid bij zwangerschapscholestase?
- Wat is de onderbouwing van het beleid bij zwangerschapscholestase?
Alsulyman, O. M., Ouzounian, J. G., Ames-Castro, M., & Goodwin, T. M. (1996). Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. American journal of obstetrics and gynecology, 175(4 Pt 1), 957-960. https://doi.org/10.1016/s0002-9378(96)80031-7 Arthuis C, Diguisto C, Lorphelin H, Dochez V, Simon E, Perrotin F, et al. (2020) Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study. PLoS ONE 15(2): e0228213. https://doi.org/10.1371/journal.pone.0228213 Bacq, Y., Sapey, T., Bréchot, M. C., Pierre, F., Fignon, A., & Dubois, F. (1997). Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology (Baltimore, Md.), 26(2), 358-364. https://doi.org/10.1002/hep.510260216 Bacq, Y., Gendrot, C., Perrotin, F., Lefrou, L., Chrétien, S., Vie-Buret, V., Brechot, M. C., & Andres, C. R. (2009). ABCB4 gene mutations and single-nucleotide polymorphisms in women with intrahepatic cholestasis of pregnancy. Journal of medical genetics, 46(10), 711-715. https://doi.org/10.1136/jmg.2009.067397 Chappell, L. C., Bell, J. L., Smith, A., Linsell, L., Juszczak, E., Dixon, P. H., Chambers, J., Hunter, R., Dorling, J., Williamson, C., Thornton, J. G., & PITCHES study group (2019). Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet (London, England), 394(10201), 849-860. https://doi.org/10.1016/S0140-6736(19)31270-X Cui, D., Zhong, Y., Zhang, L., & Du, H. (2017). Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. The journal of obstetrics and gynaecology research, 43(9), 1411-1420. https://doi.org/10.1111/jog.13399 Di Mascio, D., Quist-Nelson, J., Riegel, M., George, B., Saccone, G., Brun, R., Haslinger, C., Herrera, C., Kawakita, T., Lee, R. H., Benedetti Panici, P., & Berghella, V. (2021). Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: a systematic review. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 34(21), 3614-3622. https://doi.org/10.1080/14767058.2019.1685965 Floreani, A., & Gervasi, M. T. (2016). New Insights on Intrahepatic Cholestasis of Pregnancy. Clinics in liver disease, 20(1), 177-189. https://doi.org/10.1016/j.cld.2015.08.010 Furrer, R., Winter, K., Schäffer, L., Zimmermann, R., Burkhardt, T., & Haslinger, C. (2016). Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy. Obstetrics and gynecology, 128(5), 1048-1052. https://doi.org/10.1097/AOG.0000000000001693 Gabzdyl, E. M., & Schlaeger, J. M. (2015). Intrahepatic cholestasis of pregnancy: a critical clinical review. The Journal of perinatal & neonatal nursing, 29(1), 41-50. https://doi.org/10.1097/JPN.0000000000000077 Gao, X. X., Ye, M. Y., Liu, Y., Li, J. Y., Li, L., Chen, W., Lu, X., Nie, G., & Chen, Y. H. (2020). Prevalence and risk factors of intrahepatic cholestasis of pregnancy in a Chinese population. Scientific reports, 10(1), 16307. https://doi.org/10.1038/s41598-020-73378-5 Geenes, V., & Williamson, C. (2009). Intrahepatic cholestasis of pregnancy. World journal of gastroenterology, 15(17), 2049-2066. https://doi.org/10.3748/wjg.15.2049 Ghent C. N. (1987). Pruritus of cholestasis is related to effects of bile salts on the liver, not the skin. The American journal of gastroenterology, 82(2), 117-118. Glantz, A., Marschall, H. U., & Mattsson, L. A. (2004). Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology (Baltimore, Md.), 40(2), 467-474. https://doi.org/10.1002/hep.20336 Grand'Maison, S., Durand, M., & Mahone, M. (2014). The effects of ursodeoxycholic acid treatment for intrahepatic cholestasis of pregnancy on maternal and fetal outcomes: a meta-analysis including non-randomized studies. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 36(7), 632-641. https://doi.org/10.1016/S1701-2163(15)30544-2 Hämäläinen, S. T., Turunen, K., Mattila, K. J., Kosunen, E., & Sumanen, M. (2019). Intrahepatic cholestasis of pregnancy and comorbidity: A 44-year follow-up study. Acta obstetricia et gynecologica Scandinavica, 98(12), 1534-1539. https://doi.org/10.1111/aogs.13695 Heinonen, S., & Kirkinen, P. (1999). Pregnancy outcome with intrahepatic cholestasis. Obstetrics and gynecology, 94(2), 189-193. https://doi.org/10.1016/s0029-7844(99)00254-9 Kalfarentzos, F., Vagenas, K., Spiliotis, J., & Androulakis, J. (1986). The role of hypoalbuminemia in the development of the TPN-associated cholestasis. Clinical nutrition (Edinburgh, Scotland), 5(4), 193-195. https://doi.org/10.1016/0261-5614(86)90024-5 Lee, R. H., Kwok, K. M., Ingles, S., Wilson, M. L., Mullin, P., Incerpi, M., Pathak, B., & Goodwin, T. M. (2008). Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. American journal of perinatology, 25(6), 341-345. https://doi.org/10.1055/s-2008-1078756 Martineau, M., Raker, C., Powrie, R., & Williamson, C. (2014). Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. European journal of obstetrics, gynecology, and reproductive biology, 176, 80-85. https://doi.org/10.1016/j.ejogrb.2013.12.037 Meng, L. J., Reyes, H., Palma, J., Hernandez, I., Ribalta, J., & Sjövall, J. (1997). Effects of ursodeoxycholic acid on conjugated bile acids and progesterone metabolites in serum and urine of patients with intrahepatic cholestasis of pregnancy. Journal of hepatology, 27(6), 1029-1040. https://doi.org/10.1016/s0168-8278(97)80147-x Nanji, A. A., & Anderson, F. H. (1984). Relationship between serum albumin and parenteral nutrition-associated cholestasis. JPEN. Journal of parenteral and enteral nutrition, 8(4), 438-439. https://doi.org/10.1177/0148607184008004438 NVOG (2011). Zwangerschapscholestase. Monodisciplinaire richtlijn. https://www.nvog.nl/wp-content/uploads/2018/08/Zwangerschapscholestase-NVOG-23-3-2011.pdf Ovadia, C., Seed, P. T., Sklavounos, A., Geenes, V., Di Ilio, C., Chambers, J., Kohari, K., Bacq, Y., Bozkurt, N., Brun-Furrer, R., Bull, L., Estiú, M. C., Grymowicz, M., Gunaydin, B., Hague, W. M., Haslinger, C., Hu, Y., Kawakita, T., Kebapcilar, A. G., Kebapcilar, L., … Williamson, C. (2019). Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet (London, England), 393(10174), 899-909. https://doi.org/10.1016/S0140-6736(18)31877-4 Ovadia, C., Sajous, J., Seed, P. T., Patel, K., Williamson, N. J., Attilakos, G., Azzaroli, F., Bacq, Y., Batsry, L., Broom, K., Brun-Furrer, R., Bull, L., Chambers, J., Cui, Y., Ding, M., Dixon, P. H., Estiú, M. C., Gardiner, F. W., Geenes, V., Grymowicz, M., … Williamson, C. (2021). Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. The lancet. Gastroenterology & hepatology, 6(7), 547-558. https://doi.org/10.1016/S2468-1253(21)00074-1 Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011). Drug-induced cholestasis. Hepatology (Baltimore, Md.), 53(4), 1377-1387. https://doi.org/10.1002/hep.24229 Pauli-Magnus, C., Meier, P. J., & Stieger, B. (2010). Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. Seminars in liver disease, 30(2), 147-159. https://doi.org/10.1055/s-0030-1253224 Pillarisetty, L. S., & Sharma, A. (2021). Pregnancy Intrahepatic Cholestasis. In StatPearls. StatPearls Publishing. Puljic, A., Kim, E., Page, J., Esakoff, T., Shaffer, B., LaCoursiere, D. Y., & Caughey, A. B. (2015). The risk of infant and fetal death by each additional week of expectant management in intrahepatic cholestasis of pregnancy by gestational age. American journal of obstetrics and gynecology, 212(5), 667.e1-667.e6675. https://doi.org/10.1016/j.ajog.2015.02.012 RCOG.(2011). Obstetric Cholestasis. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_43.pdf Reddick, K. L., Jhaveri, R., Gandhi, M., James, A. H., & Swamy, G. K. (2011). Pregnancy outcomes associated with viral hepatitis. Journal of viral hepatitis, 18(7), e394-e398. https://doi.org/10.1111/j.1365-2893.2011.01436.x Reyes, H., Báez, M. E., González, M. C., Hernández, I., Palma, J., Ribalta, J., Sandoval, L., & Zapata, R. (2000). Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. Journal of hepatology, 32(4), 542-549. https://doi.org/10.1016/s0168-8278(00)80214-7 Smith, D. D., & Rood, K. M. (2020). Intrahepatic Cholestasis of Pregnancy. Clinical obstetrics and gynecology, 63(1), 134-151. https://doi.org/10.1097/GRF.0000000000000495 Walker, K. F., Chappell, L. C., Hague, W. M., Middleton, P., & Thornton, J. G. (2020). Pharmacological interventions for treating intrahepatic cholestasis of pregnancy. The Cochrane database of systematic reviews, 7(7), CD000493. https://doi.org/10.1002/14651858.CD000493.pub3 Wasmuth, H. E., Glantz, A., Keppeler, H., Simon, E., Bartz, C., Rath, W., Mattsson, L. A., Marschall, H. U., & Lammert, F. (2007). Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut, 56(2), 265-270. https://doi.org/10.1136/gut.2006.092742 Waugh, A., & Grant, A. (2021). Ross en Wilson Anatomie en Fysiologie in gezondheid en ziekte (13th edition). Elsevier Gezondheidszorg. Wijarnpreecha, K., Thongprayoon, C., Sanguankeo, A., Upala, S., Ungprasert, P., & Cheungpasitporn, W. (2017). Hepatitis C infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology, 41(1), 39-45. https://doi.org/10.1016/j.clinre.2016.07.004 Wikström Shemer, E., Marschall, H. U., Ludvigsson, J. F., & Stephansson, O. (2013). Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study. BJOG : an international journal of obstetrics and gynaecology, 120(6), 717-723. https://doi.org/10.1111/1471-0528.12174 Wolfhagen, F. H. J., Engelkens, H. J. H., & Van Buren, H. R. (1998). De pathofysiologie en behandeling van cholestatische jeuk. Ned Tijdschr Geneesk, 142, 688-692. https://www.ntvg.nl/artikelen/de-pathofysiologie-en-behandeling-van-cholestatische-jeuk#LIT6 Zecca, E., De Luca, D., Marras, M., Caruso, A., Bernardini, T., & Romagnoli, C. (2006). Intrahepatic cholestasis of pregnancy and neonatal respiratory distress syndrome. Pediatrics, 117(5), 1669-1672. https://doi.org/10.1542/peds.2005-1801 Zorginstituut Nederland. (2021d, november 17). ursodeoxycholzuur. Farmacotherapeutischkompas.nl. Geraadpleegd op 6 februari 2022, van https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/u/ursodeoxycholzuur Zorginstituut Nederland. (2021e, december 20). dexamethason (systemisch). farmacotherapeutischkompas.nl. Geraadpleegd op 6 februari 2022, van https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/d/dexamethason__systemisch_ Zorginstituut Nederland. (2021b, augustus 3). colestyramine. farmacotherapeutischkompas.nl. Geraadpleegd op 6 februari 2022, van https://www.farmacotherapeutischkompas.nl/bladeren/preparaatteksten/c/colestyramine Zu, Y., Yang, J., Zhang, C., & Liu, D. (2021). The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives. Frontiers in Pharmacology, 12. https://doi.org/10.3389/fphar.2021.761255
Reacties